NEW YORK, June 13, 2018 /PRNewswire/ -- Bernstein
Liebhard LLP is investigating potential securities fraud claims on
behalf of shareholders of Akers Biosciences, Inc. ("Akers" or the
"Company") (NASDAQ: AKER). If you purchased Akers securities,
and/or have information relating to this matter, please visit our
AKERS SHAREHOLDER PAGE or contact Daniel Sadeh toll free at (877) 779-1414 or
dsadeh@bernlieb.com.
On May 21, 2018, during
aftermarket hours, Akers revealed that its ongoing review of the
characterization of certain revenue recognition items for the
quarter ended March 31, 2018 "now
includes certain transactions in previous quarters." As a result,
Akers stated that "the Company is unable to file its 10-Q for the
quarter ended March 31, 2018
today."
On this news, Akers' stock fell $0.058 per share, or over 8%, from its previous
closing price to close at $0.599 per
share on May 22, 2018.
On May 29, 2018, Akers revealed
"that Raymond F. Akers Jr., Ph.D has
resigned as a director of the Company with immediate effect."
On this news, Akers' stock fell $0.263 per share, or over 44%, over two
consecutive trading days to close at $0.326 per share on May
30, 2018.
Then, on June 1, 2018, Akers filed
a Form 8-K with the SEC attaching a letter from Raymond Akers to the Company. In the letter, Mr.
Akers stated that "I have resigned from the Board of Directors due
to significant differences regarding the policies and practices of
the Board of Directors, accounting and business practices of
Management, and new Counsel. I believe this to be in the best
interests of the Company, shareholders, and me."
Since 1993, Bernstein Liebhard LLP has recovered over
$3.5 billion for its clients. In
addition to representing individual investors, the Firm has been
retained by some of the largest public and private pension funds in
the country to monitor their assets and pursue litigation on their
behalf. As a result of its success litigating hundreds of lawsuits
and class actions, the Firm has been named to The National Law
Journal's "Plaintiffs' Hot List" thirteen times and listed in
The Legal 500 for ten consecutive years.
Please follow us for updates on
LinkedIn: https://www.linkedin.com/company/bernstein-liebhard-llp/
and Twitter: https://twitter.com/bernlieb.
ATTORNEY ADVERTISING. © 2018 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
Contact Information
Daniel Sadeh
Bernstein Liebhard LLP
http://www.bernlieb.com
(877) 779-1414
dsadeh@bernlieb.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/akers-shareholders-bernstein-liebhard-llp-announces-investigation-of-akers-biosciences-inc---aker-300665252.html
SOURCE Bernstein Liebhard LLP